Ghana Essential Medicines List

Publication date: 2004

Ghana Essential Medicines List REPUBLIC OF GHANA Ministry of Health Ghana National Drugs Programme (GNDP) Fifth Edition, 2004 © 2004 Ministry of Health (GNDP) Ghana All rights reserved. No part of this publication may be reproduced, stored in a retrival system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording and/or otherwise, without prior written permission of the Ministry of Health, Ghana Essential Drugs List & National Formulary with Therapeutic Guidelines, 1st Edition, 1988 Essential Drugs List & National Formulary with Therapeutic Guidelines, 2nd Edition, 1993 Essential Drugs List & National Formulary with Therapeutic Guidelines, 3rd Edition, 1996 Ghana Essential Drugs List, 4th Edition, 2000 Ghana Essential Medicines List, 5th Edition, 2004 ISBN 9988-8283-2-2 For all enquiries write to the publishers: Ghana National Drugs Programme (GNDP) Ministry of Health P.O. Box MB-582, Accra, Ghana, West Africa Tel: +233 (0) 21 661 670/1 Fax: +233 (0) 21 664309 E-mail: gndp@ighmail.com Website: www.moh-ghana.org Printed by Yamens Press Limited, Accra, Ghana, West Africa. Tel: +233 (0) 21 223 222 Materials Development Consultant: E.T.A. Abbey P.O. Box AN 5116 Accra, Ghana, West Africa Tel: + 233 (0) 21 304 211/+233 (0) 21 313 843 Page 1 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. ACKNOWLEDGEMENTS The review of the Essential Medicines List (EML) 2004 by the Ministry of Health has been successful largely due to the contributions from doctors, pharmacists, nurses and other health professionals from the public and the private sectors. We are grateful to the Ghana National Drugs Programme Steering Committee, the Standard Treatment Guidelines (STG) Expert Committee, the Essential Drugs List Review Committee, all Regional Directors of Health Services, all Teaching Hospitals, and all professional medical, pharmaceutical and nursing associations, Industry, Universities and individuals who contributed to the review process. It is impossible to name everyone who contributed to this edition. We thank you all for making this publication a reality. We are especially grateful to the Dutch Government and the Royal Netherlands Embassy, Accra for the generous financial assistance provided to the Ministry of Health for management support to the pharmaceutical sector in Ghana under the Ghana National Drugs Programme (GNDP) through which this activity was funded. The World Health Organisation (WHO) is also acknowledged for the financial and technical support provided for the development and publication of this edition. The members of these various committees are: MOH/GHS Executives: STG Expert Committee Members: Hon. M. Dani-Baah Hon. Deputy Minister for Health Dr. K. Ahmed Chief Medical Officer, Ministry of Health (MOH) Prof. A. B. Akosa Director-General, Ghana Health Service Mr. S. Boateng Director, Procurement & Supplies, MOH Dr. S. Akor Director, Policy, Planning, Monitoring & Evaluation, MOH Dr. S. Adjei Deputy Director-General, Ghana Health Service Dr. T. N. Awua Siaw Institutional Care Division, Ghana Health Service Mr. F. Yellu Chief Pharmacist, Ghana Health Service Mrs. J. Azeez Drugs Manager, Procurement Unit, MOH Dr. K. Aboah Department of Surgery, School of Medical Sciences, Kwame Nkrumah University of Science & Technology Prof. H. Addo Department of Medicine, University of Ghana Medical School Mr. P. Anum National Drugs Information Centre, Pharmacy Council Dr. K. Aryee Department of Obstetrics & Gynaecology, University of Ghana Medical School Dr. A. N. O. Dodoo Centre for Tropical Clinical Pharmacology & Therapeutics, University of Ghana Medical School Prof. E. H. Frimpong Department of Medical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science & Technology Dr. G. Klufio Department of Surgery, University of Ghana Medical School Prof. M. O. Mate- Kole Department of Medicine, University of Ghana Medical School Mr. A. Mensah Department of Pharmacy, Komfo Anokye Teaching Hospital Prof. S. Naaeder Department of Surgery, University of Ghana Medical School Mrs. F. A. Nkansah Department of Pharmacy, Korle Bu Teaching Hospital Dr. F. Ofei Department of Medicine, University of Ghana Medical School Page 2 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. STG Editorial Committee Members: Programme Managers: Royal Netherlands Embassy: World Health Organisation (WHO) Management Sciences for Health (MSH) Dr. (Mrs.) E. Ofori- Adjei University Health Services, University of Ghana Dr. S. Ohene Department of Psychiatry, University of Ghana Medical School Dr. I. Owusu Department of Medicine, School of Medical Sciences, Kwame Nkrumah University of Science & Technology Dr. (Mrs.) B. Quarm-Goka Department of Child Health, University of Ghana Medical School Mr. R. Tetteh Department of Pharmacy, Korle Bu Teaching Hospital Dr. (Mrs.) J. Welbeck Department of Child Health, University of Ghana Medical School Dr. A. N. O. Dodoo Centre for Tropical Clinical Pharmacology & Therapeutics, University of Ghana Medical School Prof. M. O. Mate- Kole Department of Medicine, University of Ghana Medical School Mr. A. Mensah Department of Pharmacy, Komfo Anokye Teaching Hospital Prof.S. Naaeder Department of Surgery, University of Ghana Medical School Mrs. F. A. Nkansah Department of Pharmacy, Korle Bu Teaching Hospital Dr. F. Ofei Department of Medicine, University of Ghana Medical School Dr. (Mrs.) E.Ofori- Adjei University Health Services, University of Ghana Dr. N. A. Addo National AIDS/STI Control Programme Dr.K.O. Antwi-Agyei Expanded Programme on Immunization (EPI), (GHS) Dr. (Mrs.) C. Bart-Plange National Malaria Control Programme, (GHS) Dr. F. Bonsu National Tuberculosis Programme, (GHS) Dr. J. Gyapong Onchocerciasis Control Programme Dr. (Mrs.) M. Hagan Eyecare Programme, (GHS) Dr. (Mrs.) H. Odoi-Agyarko Reproductive and Childhealth Unit, (GHS) Dr. R.K. Osei Ag. Head, Disease Control Unit, Ghana Health Service (GHS) Dr. (Mrs.) I. Sagoe-Moses Intergrated Management of Childhood Illnesses (IMCI) Dr. Jan van der Horst Health, Women and Development Advisor Dr. M. George The Country Representative, WHO, Ghana Ms. E. Andrews National Professional Officer, Essential Drugs and Medicines Policy Page 3 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. GNDP Steering Committee GNDP Team: PREFACE Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2004 for Ghana has been derived from its companion Standard Treatment Guidelines 2004 to ensure harmony in treatment, procurement and re-imbursements. I hope that all health providers would embrace this document as it continues to be an important tool in the management of medicines in the country while the Ministry strives to increase access to essential medicines that satisfy the priority health care needs of all Ghanaians. Dr. Kwaku Afriyie Hon. Minister of Health December 2004 Dr. G. Tetteh MSH/RPM Plus Hon. M. Dani-Baah Hon. Deputy Minister for Health Mad. S. Abdul-Salam Director, Admin., Ministry of Health (MOH) Dr. K. Ahmed Chief Medical Officer, (MOH) Prof. A. B. Akosa Director-General, Ghana Health Service Mr. S. Boateng Director, Procurement & Supplies, MOH Dr. S. Akor Director, Policy, Planning, Monitoring & Evaluation, MOH Mr. P. Nomo Financial Controller, MOH Prof. D. Ofori-Adjei Director, Noguchi Memorial Institute for Medical Research (NMIMR) Mr. F. Yellu Chief Pharmacist, Ghana Health Service Mr. H.K. Abutiate Chairperson, Pharmacy Council Prof. G. Lutterodt Chairperson, Food & Drugs Board Dr. I. Agyepong Regional Director of Health Services, GAR Mrs. M. Gyansa-Lutterodt Ag. Programme Manager, GNDP Prof. D. Ofori-Adjei Technical Consultant Mrs. M. Gyansa-Lutterodt Ag. Programme Manager Ms. N. Frempong Programme Officer Dr. (Mrs.) Priscillia Nortey STG Review Co-ordinator Mrs. S. Ntow Programme Accountant Ms. M. Amoah Office Manager Page 4 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. INTRODUCTION The medicines listed in this document are derived from the revised Standard Treatment Guidelines (2004) of the Ministry of Health. The criteria used to guide the selection of medicines were dependent on those used for the selection of medicines for the World Health Organisation Model List of Essential Medicines The revision of the Standard Treatment Guidelines was based on published evidence or expert opinion. The final document was then field-tested among all categories of health professionals. As a consequence, medicines mentioned for the treatment of health problems in the Standard Treatment Guidelines have been included in this edition of the Essential Medicines List. In addition, comments on the 2000 Essential Medicines List collected from health professionals were considered on the basis of the WHO criteria by an expert panel. The criteria are: • drug selection should be based on the results of efficacy and safety evaluations obtained in controlled clinical trials and epidemiological studies, and on the performance in general use in a variety of medical settings; • when several drugs are available for the same indication, only the drug and the pharmaceutical form that provides the more convenient benefit/risk ratio should be selected; • when two or more drugs are therapeutically equivalent, the selection should fall on: - the drug that has been more thoroughly investigated, - the drug with the most favourable pharmacokinetic properties, - the drug with the lowest cost, calculated on the basis of the whole course of treatment, - the drug with which health workers are already familiar, - the drug for which economically convenient manufacturing is available in the country, - the drug which shows better stability at the available storage conditions; A fixed dose combination should be accepted only if clinical documentation justifies the concomitant use of more than one drug, and the combination provides a proven advantage over single compounds administered separately in therapeutic effect, safety, patients' compliance or cost. Furthermore, guidelines are proposed to confine the circulation of essential drugs to specific and appropriate settings and levels of health care delivery. For this, drugs have been grouped into the following categories: Level A - Community Level B1 - Health Centre without Doctor Level B2 - Health Centre with Doctor Level C - District Hospital Level D - Regional/Teaching Hospital Page 5 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. Specialist Drugs are restricted for use by qualified specialists who may request for them. Programme Drugs are those drugs used in public health programmes of the Ministry of Health and as such used within the guidelines of the specific programmes. In previous editions, the British Appoved Name (BAN) was adopted for all medicines in the Essential Medicines List (EML). This current issue uses only the Recommended International Non- Proprietary Name (rINN) in line with WHO recommendations and practice. It is the hope of the Ministry that health professionals will support this document by providing comments and suggestions towards to inform the next review Comments and suggestions should be sent to: The Programme Manager Ghana National Drugs Programme Ministry of Health P.O. Box MB-582 Accra, Ghana Tel +233 (0) 21 661 670/1 Fax: +233 (0) 21 664309 E-mail: gndp@ighmail.com ESSENTIAL MEDICINES LIST 1 ANAESTHETICS Level SD - Specialist Drugs Level PD - Programme Drugs THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 1.1 GENERAL ANAESTHETICS Halothane, Inhalation C Isoflurane, Inhalation SD Ketamine Injection, 10 mg/ml in 20 ml C Ketamine Injection, 100 mg/ml in 10 ml C Nitrous Oxide, Inhalation C Oxygen (Medicinal Gas) Inhalation C Propofol Injection, 10 mg/ml D Thiopental Sodium Injection, 500 mg C Thiopental Sodium Injection, 1 g C 1.2 LOCAL ANAESTHETICS Bupivacaine + Glucose Injection, (5 mg+80 mg) in 4ml D Bupivacaine Injection, 2.5 mg/ml D Bupivacaine Injection, 5 mg/ml D Lidocaine Gel, 2% B1 Lidocaine Gel, 4% B1 Page 6 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 2 PRE-OPERATIVE MEDICATIONS AND SEDATION FOR SHORT-TERM PROCEDURES 3 ANALGESICS, ANTIPYRETICS, NSAIDS AND DRUGS USED IN GOUT Lidocaine Injection, 0.5% B1 Lidocaine Injection, 1% D Lidocaine Injection, 2% B Lidocaine Spray, 10% B1 Lidocaine+Adrenaline Injection, 10 mg/ml+5 microgram/ml B2 Lidocaine+Adrenaline Injection, 20 mg/ml+5 microgram/ml B2 Prilocaine Injection, 10 mg/ml D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Atropine Injection, 0.6 mg/ml B2 Diazepam Injection, 5 mg/ml B1 Doxapram Injection, 20 mg/ml in 5 ml D Ephedrine HCl Injection, 3 mg/ml D Glycopyrronium Injection, 200 microgram/ml D Lorazepam Injection,4 mg/ml D Midazolam Injection, 2 mg/ml D Midazolam Injection, 5mg/ml D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 3.1 NON-OPIOD NON-STEROIDAL ANALGESICS Acetyl Salicylic Acid Tablet, 300 mg A Allopurinol Tablet, 100 mg C Allopurinol Tablet, 300 mg C Diclofenac Injection, 25 mg/ml B2 Diclofenac Suppository, 50 mg C Diclofenac Suppository, 100 mg C Diclofenac Tablet, 25 mg B2 Diclofenac Tablet, 50 mg B2 Ibuprofen Suspension, 100mg/5ml B1 Ibuprofen Tablet, 200 mg B1 Ibuprofen Tablet, 400 mg B2 Paracetamol Suppository, 125 mg B1 Paracetamol Suppository, 250 mg B1 Paracetamol Syrup, 120 mg/5 ml A Paracetamol Tablet, 500 mg A Page 7 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 4 ANTI-ALLERGIC DRUGS 5 ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING 6 ANTICONVULSANTS 3.2 OPIOD ANALGESICS Fentanyl Citrate Injection, 50 microgram/ml D Morphine Injection, 10 mg/ml C Morphine Injection, 10 mg/ml (Preservative Free) SD Morphine Sulphate Tablet, 30 mg (Slow release) D Pethidine Injection, 50 mg/ml in 2 ml B2 THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Adrenaline Injection, (1:1000) 1 mg/ml B1 Cetirizine Tablet, 10 mg C Chlorphenamine Syrup, 2 mg/5 ml B1 Chlorphenamine Tablet, 4 mg B1 Dexamethasone Tablet, 500 microgram C Diphenhydramine Tablet, 25 mg B1 Hydrocortisone Sodium Succinate Injection, 100 mg B1 Prednisolone Tablet, 5 mg C Promethazine Elixir, 5 mg/5 ml B1 Promethazine Injection, 25 mg/ml in 2 ml B1 Promethazine Tablet, 25 mg B1 THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 5.1 NON-SPECIFIC ANTIDOTES Activated Charcoal Powder, 50 g C Ipecacuanha Emetic Mixture, BP C 5.2 SPECIFIC ANTIDOTES Acetylcysteine Injection, 200 mg/ml C Atropine Injection, 0.6 mg/ml B2 Benzatropine Injection, 1 mg/ml C Naloxone Injection, 400 microgram/ml B2 Polystyerene Sulphonate Resins Powder, 300g C Protamine Sulphate Injection, 10mg/ml D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Carbamazepine Tablet, 100 mg D Carbamazepine Tablet, 200 mg D Diazepam Injection, 5 mg/ml in 2 ml B1 Page 8 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 7 ANTI-INFECTIVE DRUGS Diazepam Rectal Tubes, 2 mg/ml B1 Ethosuximide Syrup, 250 mg/5 ml D Ethosuximide Capsule, 250 mg D Magnesium Sulphate Injection, 20% C Magnesium Sulphate Injection, 25% C Magnesium Sulphate Injection, 50% C Phenobarbitone Elixir, 15 mg/5 ml B2 Phenobarbital Injection, 200 mg/ml B2 Phenobarbital Tablet, 30 mg B2 Phenobarbital Tablet, 60 mg B2 Phenytoin Sodium Capsule, 100 mg B2 Phenytoin Injection, 50 mg/ml D Phenytoin Sodium Tablet, 100 mg B2 Primidone Tablet, 250 mg C Sodium Valproate Tablet, 200 mg D Sodium Valproate Syrup, 200 mg/5ml D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 7.1 ANTIHELMINTHIC DRUGS 7.1.1 Intestinal Antihelminthic Drugs Albendazole Syrup, 100 mg/5ml B1 Albendazole Tablet, 200 mg B1 Mebendazole Tablet, 100 mg B1 Mebendazole Tablet, 500 mg B1 Niclosamide Tablet, 500 mg C Tiabendazole Suspension, 50 mg/ml C Tiabendazole Tablet, 500 mg C 7.1.2 Antifilarial Drugs Diethylcarbamazine Tablet, 50 mg B1 Ivermectin Tablet, 6 mg B1 7.1.3 Antischistosomal Drugs Praziquantel Tablet, 600 mg B2 7.2 ANTIBACTERIAL DRUGS 7.2.1 Penicillins Amoxicillin Capsule, 250 mg B1 Amoxicillin Capsule, 500 mg B1 Amoxicillin Suspension, 125 mg/5 ml B2 Amoxicillin + Clavulanic acid Suspension, 250mg + 62 mg C Amoxicillin + Clavulanic acid Suspension, 400mg + 57 mg C Page 9 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. Amoxicillin + Clavulanic acid Injection, 500 mg + 100 mg C Amoxicillin + Clavulanic acid Tablet, 500 mg + 125 mg C Ampicillin Injection, 500 mg C Benzathine Benzylpenicillin Injection, 1.2 MU B1 Benzathine Benzylpenicillin Injection, 2.4 MU B1 Benzyl Penicillin Injection, 1 MU B2 Benzyl Penicillin Injection, 5 MU B2 Cloxacillin Injection, 250 mg B2 Cloxacillin Injection, 500 mg B2 Flucloxacillin Capsule, 250 mg B2 Flucloxacillin Injection, 250 mg C Flucloxacillin Injection, 500 mg C Flucloxacillin Suspension, 125 mg/5 ml B2 Phenoxymethyl Penicillin Tablet, 250 mg B1 Procaine benzylpenicillin Injection, 4 MU B1 Tetracycline Capsule, 250mg B1 7.2.2 Other Antibacterial Drugs Azithromycin Capsule, 250 mg C Azithromycin Oral suspension, 200 mg/5 ml C Cefotaxime Injection, 1 g D Cefotaxime Injection, 500 mg D Ceftriazone Injection, 1g vial D Ceftriazone Injection, 250 mg vial PD Cefuroxime Injection, 750 mg vial D Cefuroxime Injection, 1.5 mg vial D Cefuroxime Tablet, 250 mg D Chloramphenicol Capsule, 250 mg B2 Chloramphenicol Injection, 1g C Chloramphenicol Suspension, 250 mg/5 ml B2 Ciprofloxacin Infusion, 2 mg/ml in 100ml D Ciprofloxacin Tablet, 250 mg PD Ciprofloxacin Tablet, 500 mg PD Clarithromycin Tablet, 250 mg D Clarithromycin Tablet, 500 mg D Clarithromycin Paediatric Suspension, 125 mg/5 ml D Clindamycin Capsule, 150 mg D Clindamycin Injection, 150 mg/ml in 2ml D Cotrimoxazole Suspension, (200 mg+40 mg)/5 ml B1 Cotrimoxazole Tablet, (400 mg+80 mg) B1 Doxycycline Capsule, 100 mg PD Erythromycin Injection, 500 mg D Erythromycin Injection, 1 g D Erythromycin Syrup, 125 mg/5 ml C Page 10 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. Erythromycin Tablet, 250 mg C Gentamicin Injection, 40 mg/ml in 2 ml C Neomycin Tablet, 500 mg C Nitrofurantoin Tablet, 100 mg B2 7.2.3 Antileprosy Drugs Antileprosy Pack (Clofazimine Tablet, 100 mg, Dapsone Tablet, 50 mg, Rifampicin Capsule, 300 mg) PD Dapsone Tablet, 100 mg D 7.2.4 Antituberculous Drugs Ethambutol Tablet, 400 mg PD Isoniazid Tablet, 100 mg PD Isoniazid+Thiacetazone Tablet, (300 mg+150 mg) PD Pyrazinamide Suspension, 125 mg/5 ml PD Pyrazinamide Tablet, 500 mg PD Rifampicin Tablet, 150mg PD Rifampicin + Isoniazid Suspension, 75 mg+50 mg/5 ml PD Rifampicin+Isoniazid Tablet, 150 mg+100 mg PD Streptomycin Injection, 1 g PD Thiacetazone Tablet, 150 mg PD 7.3 ANTIFUNGAL DRUGS FOR SYSTEMIC USE Fluconazole Capsule, 50 mg SD Fluconazole Capsule, 200 mg SD Griseofulvin Tablet, 125 mg C Griseofulvin Tablet, 500 mg C Ketoconazole Tablet, 200 mg D Nystatin Suspension, 100,000 IU/ml B2 Nystatin Pastilles, 100,000 IU C Nystatin Tablet, 500,000 IU C Terbinafine HCl, Tablet, 250 mg SD 7.4 ANTIPROTOZOAL DRUGS 7.4.1 Anti-Amoebic Drugs Metronidazole Injection, 5 mg/ml in 100 ml D Metronidazole Suppository, 500 mg C Metronidazole Suspension, 100 mg/5ml (as benzoate) B1 Metronidazole Suspension, 200 mg/5 ml (as benzoate) B2 Metronidazole Tablet, 200 mg B1 Metronidazole Tablet, 400 mg B1 7.4.2 Antileishmaniasis Drugs Pentamidine isetionate Injection, 300 mg vial C Page 11 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 8 ANTIMIGRAINE DRUGS 9 ANTINEOPLASTIC AND IMMUNOSUPPRESIVE DRUGS 7.4.3 Antimalarial Drugs Amodiaquine Syrup, 50 mg/ml PD Amodiaquine Tablet, 75 mg PD Amodiaquine Tablet, 150 mg PD Amodiaquine Tablet, 200 mg PD Artesunate Tablets, 25 mg PD Artesunate Tablets, 50 mg PD Artesunate Tablets, 100 mg PD Artesunate Tablets, 200 mg PD Quinine Injection, 300 mg/ml in 2 mls PD Quinine Tablet, 300 mg PD Sulfadoxine+Pyrimethamine Tablet, 525 mg PD 7.5 ANTIVIRAL Aciclovir Tablet, 200mg D Aciclovir Injection, 25mg/ml D Aciclovir Suspension, 200mg/5ml D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Acetyl Salicylic Acid Tablet, 300 mg B1 Ergotamine Tablet, 2 mg C Paracetamol Tablet, 500 mg B1 Propranolol Tablet, 40mg B2 THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 9.1 CYTOTOXIC DRUGS Fluorouracil Injection, 50 mg/5ml D Mercaptopurine Tablet, 50 mg D Dactinomycin Injection, 500 microgram D Azathioprine Tablet, 50 mg D Busulfan Tablet, 2 mg D Busulfan Tablet, 500 microgram D Cisplatin Injection, 50mg D Chlorambucil Tablet, 2 mg D Chlorambucil Tablet, 5 mg D Cyclophosphamide Injection, 500 mg D Cyclophosphamide Tablet, 25 mg D Cyclophosphamide Tablet, 50 mg D Cytosine Arabinoside Injection, 100 mg D Page 12 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 10 ANTIPARKINSONISM DRUGS 11 DRUGS AFFECTING THE BLOOD Doxorubicin Injection, 10 mg D Doxorubicin Injection, 50 mg D Folinic Acid Injection, 15 mg D Folinic Acid Tablet, 15 mg D Hydroxycarbamide Tablet, 500mg D Melphalan Tablet, 2 mg D Melphalan Tablet, 5 mg D Methotrexate Injection, 2.5 mg D Methotrexate Injection, 25 mg D Methotrexate Tablet, 2.5 mg D Methotrexate Tablet, 10 mg D Procarbazine Tablet, 50 mg D Tioguanine Tablet, 40 mg D Vincristine Injection, 1 mg/ml D Vincristine Injection, 5 mg/ml D 9.2 HORMONES AND ANTIHORMONES Anastrozole Tablet, 1mg D Prednisolone Tablet, 5 mg D Diethylstilboestrol Tablet, 1 mg D Diethylstilboestrol Tablet, 5 mg D Tamoxifen Tablet, 10 mg D Tamoxifen Tablet, 20 mg D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Trihexyphenidyl Tablet, 2 mg C Trihexyphenidyl Tablet, 5 mg C Benzatropine Injection, 1 mg/ml C Benzatropine Tablet, 2 mg C Biperiden Injection, 5 mg/ml C Biperiden Tablet, 2 mg C THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 11.1 ANTIANAEMIA DRUGS Iron + Folic Acid Tablet, 60 mg + 250 microgram A Ferric Ammonium Citrate (FAC) A Ferrous Fumarate Tablet, (100 mg Iron) B1 Ferrous Gluconate Tablet, (35 mg Iron) B1 Ferrous Sulphate (BPC) Syrup, 60 mg/5 ml B1 Page 13 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 12 BLOOD PRODUCTS AND BLOOD SUBSTITUTES 13 CARDIOVASCULAR DRUGS Ferrous Sulphate Tablet, 60 mg (Elemental Iron) B1 Folic Acid Tablet, 5 mg B1 Hydroxocobalamin Injection, 1 mg/ml C Iron Dextran Injection, 50 mg/ml C 11.2 ANTICOAGULANTS AND ANTAGONISTS Acetyl Salicylic Acid Tablet, 75 mg C Heparin [Low molecular weight] Injection, 4000 units/ml D Heparin Injection, 1000 units/ml D Heparin Injection, 5000 units/ml D Heparin Injection, 5000 units/0.2 ml D Protamine Sulphate Injection, 10mg/ml D Phytomenadione Injection, 10 mg/ml C Phytomenadione Injection, 1 mg/ml B2 Warfarin Tablet, 1 mg D Warfarin Tablet, 3 mg D Warfarin Tablet, 5 mg (scored) D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Gelatin Infusion (succinylated gelatin) C THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 13.1 ANTI-ANGINAL DRUGS Glyceryl Trinitrate Sublingual Tablet, 500 microgram C Isosorbide Dinitrate Sublingual Tablet, 5 mg C Isosorbide Dinitrate Tablet, 10 mg C Nifedipine Tablet, 10 mg (slow release) C Nifedipine Tablet, 20 mg (slow release) C Nifedipine Tablet, 30mg (GITS) C Propranolol Tablet, 10mg C Propranolol Tablet, 40 mg C Propranolol Tablet, 80 mg C 13.2 ANTIDYSRHYTHMIC DRUGS Amiodarone Tablet, 200mg SD Disopyramide Capsule, 100mg D Disopyramide Phosphate Injection, 10mg/ml D Lidocaine Injection, 20 mg/ml in 5 mls D Page 14 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. Propranolol Tablet, 10mg C Propranolol Tablet, 40 mg C Propranolol Tablet, 80 mg C 13.3 ANTIHYPERTENSIVE DRUGS Atenolol Tablet, 100 mg C Atenolol Tablet, 50 mg C Bendroflumethiazide Tablet, 2.5 mg B1 Bendroflumethiazide Tablet, 5 mg B1 Hydralazine Injection, 20 mg C Hydralazine Tablet, 25 mg C Labetalol Injection, 5 mg/ml D Labetalol Tablet, 100 mg D Labetalol Tablet, 200 mg D Lisinopril Tablet, 2.5 mg D Lisinopril Tablet, 5 mg D Lisinopril Tablet, 10 mg D Losartan Tablet, 25 mg D Losartan Tablet, 50 mg D Losartan Tablet, 100 mg D Methyldopa Tablet, 250 mg B2 Nifedipine Capsule, 10 mg D Nifedipine Capsule, 5 mg D Nifedipine Tablet, 10 mg (Slow release) C Nifedipine Tablet, 20 mg (Slow release) C Nifedipine Tablet, 30 mg (GITS) C Prazosin Tablet, 500 microgram D Propranolol Injection, 1 mg/ml D Propranolol Tablet, 10 mg B2 Propranolol Tablet, 40 mg B2 Propranolol Tablet, 80 mg B2 Reserpine Injection, 1 mg/ml B2 Reserpine Tablet, 250 microgram B1 13.4 CARDIAC GLYCOSIDES Digoxin Elixir, 50 microgram/ml C Digoxin Injection, 250 microgram/ml C Digoxin Tablet, 125 microgram C Digoxin Tablet, 250 microgram C 13.5 LIPID-REGULATING DRUGS Fluvastatin Capsules, 20mg D Page 15 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 14 DERMATOLOGICAL PREPARATIONS 13.6 DRUGS USED IN SHOCK Dopamine Injection, 40 mg/ml in 5 ml D Hydrocortisone Injection, 100 mg C THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 14.1 ANTIFUNGAL DRUGS Benzoic Acid + Salicylic Acid Ointment, 6%+3% B1 Clotrimazole + Hydrocortisone Cream, 2% + 1% D Clotrimazole Cream, 2% B2 Clotrimazole Pessary, 100 mg PD Gentian Violet Paint, 1% A Selenium Sulphide Shampoo, 2.5% C 14.2 ANTI-INFECTIVE DRUGS Aciclovir Cream, 5% C Cetrimide Solution B1 Chlorhexidine Cream, 1% B1 Chlorhexidine Solution, 2.5% B1 Silver Sulfadiazine Cream, 1% C 14.3 ANTI-INFLAMMATORY AND ANTIPRURITIC DRUGS Calamine Lotion, 15% B1 Calamine Cream, 15% B1 Clobetasol propionate Cream, 0.05% B1 Hydrocortisone Cream, 1% C 14.4 ASTRINGENT AGENTS Salicylic Acid Ointment, 2% B1 14.5 SCABICIDES AND PEDICULOCIDES Benzyl Benzoate Lotion, 25% B1 Lindane Lotion, 1% B1 14.6 EMOLLIENTS AND VEHICLES Aqueous Cream BP B1 14.7 OTHERS Benzoyl Peroxide Solution, 10% C Benzoyl Peroxide Solution, 5% C Clindamycin Solution, 1% C Mercurochrome Solution B1 Page 16 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 15 DIAGNOSTIC AGENTS 16 DISINFECTANTS 17 DIURETICS 18 GASTROINTESTINAL DRUGS THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 15.1 OPHTHALMIC DRUGS Fluorescein Solution, 2% C Fluorescein Strips C Methylcellulose Eye Drops, 1% D Methylcellulose Eye Drops, 2% D Rose Bengal Minims, 1% D Tropicamide Eye Drops, 1% C 15.2 BED-SIDE DIAGNOSTIC SUPPORT Diagnostic Strips - Glucose B1 Diagnostic Strips - Multipurpose B2 Diagnostic Strips - Protein B2 Diagnostic Tablets - Glucose B1 Diagnostic Tablets - Ketones B1 15.3 OTHERS Edrophonium Injection, 10 mg/ml D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Chlorhexidine Solution, 4% in detergent base C Chlorhexidine Cream, 1% C Chlorhexidine Solution, 2.5% B1 Iodine + Potassium Iodide Solution, 2% + 2.4% A Povidone Iodine (aq.) Solution, 10% B1 THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Bendroflumethiazide Tablet, 2.5 mg B1 Bendroflumethiazide Tablet, 5 mg B1 Furosemide Injection, 10 mg/ml in 2 ml B2 Furosemide Tablet, 40 mg B2 Mannitol Injection, 10% 500 ml C Mannitol Injection, 20% 500 ml D Metolazone Tablet, 5 mg D Spironolactone Tablet, 25 mg C Spironolactone Tablet, 50 mg C Page 17 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 18.1 ANTACIDS AND OTHER ANTIULCER DRUGS Magnesium Trisilicate Mixture B1 Magnesium Trisilicate Tablet, 500 mg A Omeprazole Capsule, 20 mg D Ranitidine Injection, 25 mg/ml in 2ml C Ranitidine Tablet, 150 mg C 18.2 ANTI-EMETICS Metoclopramide Injection, 5 mg/ml in 2 mls D Metoclopramide Tablet, 10 mg C Ondansetron Injection, 2 mg/ml SD Ondansetron Tablet, 4 mg SD Promethazine Hydrochloride Elixir, 5 mg/5 ml B2 Promethazine Hydrochloride Injection, 25 mg/ml B2 Promethazine Theoclate Tablet, 25 mg B2 18.3 ANTIHAEMORRHOIDAL DRUGS Ethanolamine Oleate Solution, 5% D Phenol 5% in Almond Oil Injection D Soothing Agent + Local Anaesthetic Ointment B2 Soothing Agent + Local Anaesthetic Suppository B2 Soothing Agent + Local Anaesthetic + Steroid Ointment C Soothing Agent + Local Anaesthetic + Steroid Suppository C 18.4 ANTI-INFLAMMATORY DRUGS Sulfasalazine Tablet, 500 mg D 18.5 ANTISPASMODIC DRUGS Hyoscine Butylbromide Tablet, 10 mg B2 Hyoscine Butylbromide Injection, 20 mg/ml B2 Mebeverine Tablet, 135 mg D 18.6 CATHARTIC DRUGS Bisacodyl Tablet, 5 mg B2 Lactulose Liquid 3.1- - 3.7 g/5 ml C Magnesium Sulphate salt C Paraffin Liquid B1 Senna Tablet, 7.5 mg or Granules B1 18.7 DRUGS USED IN DIARRHOEA 18.7.1 Oral Replacement Solution Page 18 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 19 HORMONES, OTHER ENDOCRINE DRUGS AND CONTRACEPTIVES Oral Rehydration Salts Powder A 18.7.2 Antidiarrhoeal (Symptomatic) Drugs Codeine Tablet, 30mg C THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 19.1 ADRENAL HORMONES AND SYNTHETIC SUBSTITUTES Dexamethasone Injection, 4 mg/ml C Fludrocortisone Tablet, 100 microgram D Hydrocortisone Sodium Succinate Injection, 100 mg B2 Prednisolone Tablet, 5 mg C 19.2 ANDROGENS Testosterone Enanthate Injection, 200 mg in 1 ml ampoule D 19.3 CONTRACEPTIVES Medroxyprogesterone Acetate Injection, 150 mg/ml (Depot) PD 19.4 ESTROGENS Conjugated Oestrogen Tablet, 625 microgram D Conjugated Oestrogen + Norgesterol Tablet, 625 microgram + 150 microgram C Conjugated Oestrogen Vaginal cream, 625 micrograms/g D 19.5 INSULINS AND OTHER ANTIDIABETIC DRUGS Isophane Insulin Injection (HM), 100 units/ml in 10 ml C Insulin pre-mixed (30/70) HM Injection, 100 units/ml in 10 ml C Insulin Soluble HM, 100 units/ml in 10 ml C Glibenclamide Tablet, 5 mg C Gliclazide Tablet, 80 mg C Tolbutamide Tablet, 500 mg C Metformin Tablet, 500 mg D Glucagon Injection, 1 mg C 19.6 OVULATION INDUCERS Clomifene Tablet, 50 mg D 19.7 PROGESTOGENS Medroxyprogesterone Acetate Tablet, 5 mg D Page 19 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 20 IMMUNOLOGICALS 21 MUSCLE RELAXANTS AND CHOLINESTERASE INHIBITORS* * Level of Care may be altered in accordance with type of anaesthetic machine and Norethisterone Tablet, 5 mg D 19.8 THYROID HORMONES AND ANTITHYROID DRUGS Carbimazole Tablet, 5 mg D Carbimazole Tablet, 20 mg D Levothyroxine sodium Tablet, 50 microgram D Levothyroxine sodium Tablet, 100 microgram D 19.9 OTHER ENDOCRINOLOGICAL DRUGS Bromocriptine Tablet, 2.5 mg D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 20.1 DIAGNOSTIC AGENTS Tuberculin (PPD) Injection C 20.2 SERA AND IMMUNOGLOBULINS Anti D Rh Immune Globulin Injection C Antirabies immunoglobulins Injection, 1000 IU/5ml B1 Anti-snake venom, Polyvalent Injection B1 Tetanus Immunoglobulins Injection, 250 IU/ml B1 20.3 VACCINES 20.3.1 For Universal Immunization BCG Vaccine Injection PD "Five in One" Vaccine Injection (Diphtheria, Pertussis, Tetanus, Haemophilus influenzae b and Hepatitis B) PD Hepatitis B Vaccine Injection PD Measles Vaccine Injection PD Poliomyelitis Vaccine Oral Solution PD Tetanus Vaccine Injection, 40 IU/5 ml PD Yellow Fever Vaccine Injection PD 20.3.2 For Specific Groups of Individuals Meningococcal Vaccine Injection B2 Rabies Vaccine Injection B2 Tetanus Toxoid Injection, 0.5 ml B1 Tetanus Vaccine Injection, 40 IU/5 ml B1 Yellow Fever Vaccine Injection B2 Page 20 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. personnel available 22 OPHTHALMOLOGICAL PREPARATIONS THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Atracurium Injection, 10 mg/ml in 2.5 ml D Neostigmine Injection, 2.5 mg D Neostigmine Injection, 0.5 mg D Rocuronium Injection, 10 mg/ml Suxamethonium Injection, 100 mg/2ml C Vecuronium Bromide Injection, 10 mg/vial D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 22.1 ANTI-INFECTIVE AGENTS Aciclovir Ointment, 3% D Chloramphenicol Eye Drops, 1% B1 Chloramphenicol Eye Ointment, 1% B1 Econazole Eye Drops, 1% C Erythromycin Ointment, 0.5% B1 Gentamicin Eye Drops, 0.3% D Gentamicin Ointment, 0.3% D Sulphacetamide Eye Drops, 10% B1 Sulphacetamide Ointment, 10% B1 Tetracycline Eye Drops, 0.5% 10 mls B1 Tetracycline Ointment, 1% B1 22.2 ANTI-INFLAMMATORY AGENTS Corticosteroid + Antibiotic Drops D Corticosteroid + Antibiotic Ointment D Dexamethasone Eye Drops, 1% D Dexamethasone Eye Ointment, 1% D Hydrocortisone Eye Drops, 1% D Hydrocortisone Eye Ointment, 1% D Lodoxamide Eye Drops, 0.1% D Prednisolone Eye Drops, 0.5% D Prednisolone Eye Drops, 1% D 22.3 LOCAL ANAESTHETICS Tetracaine Eye Drops, 0.5% C 22.4 MIOTICS AND DRUGS USED IN GLAUCOMA Acetazolamide Injection, 500 mg D Acetozolamide Tablet, 250 mg C Page 21 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 23 OXYTOCICS AND ANTI-OXYTOCICS 24 PERITONEAL DIALYSIS SOLUTIONS 25 PSYCHOTHERAPEUTIC DRUGS Adrenaline Eye Drops, 1% D Betaxolol HCl Eye Drops, 0.5% D Pilocarpine Eye Drops, 2% D Pilocarpine Eye Drops, 4% D Timolol Maleate Eye Drops, 0.5% D 22.5 MYDRIATICS Atropine Eye Drops, 1% D Cyclopentolate Eye Drops, 1% D Homatropine Eye Drops, 2% C 22.6 OTHERS Methyl Cellulose Eye Drops, 0.3% C THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 23.1 OXYTOCICS Ergometrine Injection, 0.5 mg/ml B1 Ergometrine Tablet, 0.5 mg A Misoprostol Vaginal Tablet,, 200 microgram C Oxytocin Injection, 5 units/ml C 23.2 ANTI-OXYTOCICS Salbutamol Sulphate Injection, 500 microgram/ml C Salbutamol Tablet, 4 mg C THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Intraperitoneal Dialysis Solution, Hypertonic D Intraperitoneal Dialysis Solution, Hypotonic D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Amitriptyline Tablet, 10 mg D Amitriptyline Tablet, 25 mg D Amitiyptyline Tablet, 50 mg D Chlorpromazine Injection, 25 mg/ml in 2 mls B2 Chlorpromazine Tablet, 100 mg B2 Chlorpromazine Tablet, 25 mg B2 Chlorpromazine Tablet, 50 mg B2 Page 22 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 26 DRUGS ACTING ON THE RESPIRATORY TRACT 27 SOLUTIONS CORRECTING WATER AND ELECTROLYTE Diazepam Injection, 5 mg/ml in 2 ml B2 Diazepam Tablet, 10 mg B2 Diazepam Tablet, 5 mg B2 Fluoxetine Capsule, 20 mg D Fluphenazine Deconoate Injection, 25 mg/ml D Haloperidol Injection, 5 mg/ml D Haloperidol Tablet, 10 mg D Haloperidol Tablet, 5 mg D Imipramine Tablet, 25 mg D Lorazepam Tablet, 2.5 mg D Risperidone Liquid, 1 mg/ml SD Risperidone Tablet, 500 microgram SD Risperidone Tablet, 1mg SD Risperidone Tablet, 2mg SD Trifluoperazine Tablet, 1 mg D Trifluoperazine Tablet, 5 mg D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 26.1 ANTI-ASTHMATIC DRUGS Adrenaline Injection, 1 mg/1ml (1:1000) B1 Aminophylline Injection, 250 mg/10 ml B2 Beclometasone dipropionate Inhaler, 100 mcg/metered dose B2 Beclometasone dipropionate Inhaler, 50 mcg/metered dose B2 Hydrocortisone Sodium Succinate Injection, 100 mg B2 Prednisolone Tablet, 5 mg C Salbutamol Inhaler, 100 microgram/metered dose, 200 doses B2 Salbutamol Nebulizer, 2.5 mg Nebules C Salbutamol Nebulizer, 5 mg Nebules C Salbutamol Syrup, 2 mg/5 ml B1 Salbutamol Tablet, 2 mg B1 Salbutamol Tablet, 4 mg B1 Theophylline Dry Syrup, 60 mg/5 ml D Theophylline Tablet, 200 mg (slow release) C 26.2 ANTITUSSIVES Dihydrocodeine Tablet, 30 mg C Simple Linctus (paediatric) B1 Simple Linctus Syrup B1 Page 23 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. ABNORMALITIES †Dextrose is used interchangeably with Glucose 28 VITAMINS AND MINERALS THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 27.1 ORAL PREPARATIONS Oral Rehydration Salts Powder A Potassium Chloride Tablet, 600 mg (enteric coated) C 27.2 PARENTERAL SOLUTIONS Badoe's Solution Injection, 1000 ml C Cholera Replacement Fluid Injection, (5:4:1) B Darrow's Solution Injection, Half-Strength 250 ml C Dextrose in Sodium Chloride Intravenous Infusion, 4.3% in 0.18% 250 ml C Dextrose in Sodium Chloride Intravenous Infusion, 5% in 0.9% (500 ml) C Dextrose† in Sodium Chloride Intravenous Infusion, 10% in 0.18% (250 ml) C Dextrose Infusion, 10% (250 ml) B2 Dextrose Infusion, 10% (500 ml) B2 Dextrose Infusion, 20% (250 ml) C Dextrose Infusion, 5% (250 ml) B Dextrose Infusion, 5% (500 ml) B Dextrose Infusion, 50% (50 ml) B2 Potassium Chloride Injection, 20 mEq/10 ml C Ringer’s Lactate Intravenous Infusion, 500 ml B2 Sodium Bicarbonate Injection, 8.4% in 10 ml C Sodium Chloride + KCl Injection, 0.9% + 20 mMol (500 ml) D Sodium Chloride in Dextrose Injection, 0.9% in 5% (500 ml) B2 Sodium Chloride Injection, 0.9% (250 ml) B1 Sodium Chloride Injection, 0.9% (500 ml) B1 Sodium Chloride Injection, 0.45% (250 ml) C 27.3 MISCELLANEOUS Water for Injection A THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE Calciferol Tablet, 10,000 units C Calcium Gluconate Injection, 100 mg/ml in 10 ml C Page 24 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. 29 OTHER SPECIALIST DRUGS Multivitamin Syrup B1 Multivitamin Tablet B1 Retinol Soft Capsule, 200,000 IU B1 Retinol Soft Capsule, 100,000 IU B1 Thiamine Injection, 100 mg D Thiamine Tablet, 25 mg D THERAPEUTIC CLASS NAME OF DRUG, DOSAGE FORM AND STRENGTH LEVEL OF CARE 29.1 DRUGS FOR EAR, NOSE AND THROAT Sodium Chloride Nasal Drops, 0.9% B1 29.2 DRUGS FOR DENTISTRY Chlorhexidine Mouthwash, 0.2% B2 Lidocaine + Adrenaline Cartridge, 20 mg/ml + [1:80,000/1:100,000] B2 Miconazole Oral gel, 25 mg/ml B2 Nystatin Ointment, 100,000 IU B2 29.3 DRUGS FOR HIV/AIDS Abacavir oral solution, 20 mg/ml SD Abacavir Tablet, 300 mg SD Didanosine Capsule, 200 mg SD Didanosine Oral solution, 10 mg/ml SD Didanosine Tablet, 25 mg, SD Didanosine Tablet, 50 mg SD Didanosine Tablet, 100 mg SD Didanosine Tablet, 150 mg SD Efavirenz Capsule, 50 mg SD Efavirenz Capsule, 100 mg SD Efavirenz Capsule, 200 mg SD Efavirenz Syrup, 30 mg/ml SD Efavirenz Tablet, 600 mg SD Indinavir Tablet, 400 mg SD Lamivudine Oral solution, 10 mg/ml SD Lamivudine Tablet, 150 mg SD Liponavir with Ritonavir Capsule, 133.3 mg + 33.3 mg SD Liponavir with Ritonavir Oral solution, 80 mg + 20 mg/ml SD Nelfinavir Tablet, 250 mg SD Nevirapine Suspension, 10 mg/ml SD Nevirapine Tablet, 200 mg SD Ritonavir Capsule, 100 mg SD Saquinavir Capsule, 200 mg SD Page 25 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. OTHER PUBLICATIONS • National Drugs Policy (2004) • Code of Ethics and Standards of Practice for Traditional Medicines Practitioners in Ghana (2004) • Standards of Pharmaceutical Care for Health Institutions in Ghana (2003) • Increasing Access to Medicines: An Assessment and Policy Options for Ghana (2003) • An Assessment of the Pharmaceutical Sector in Ghana (2002) • Logistics Management of Public Sector Health Commodities in Ghana: Standard Operating Procedures - Regional Medical Stores to Service Delivery Points (2002) • Drugs and Therapeutics Committee (DTC) Training Manual (2002) • Standard Treatment Guidelines (2000) • Ghana Essential Drugs List (2000) • Baseline Survey on the Pharmaceutical Sector in Ghana (1999) • Procurement Procedure Manual (1999) • Procurement Training Manual • Rational Drug Use Training Manual Ghana National Drugs Programme (GNDP) Ministry of Health Stavudine Capsule, 15 mg SD Stavudine Capsule, 20 mg SD Stavudine Capsule, 30 mg SD Stavudine Capsule, 40 mg SD Stavudine Oral Solution, 1 mg/ml SD Tenofovir Tablet, 300 mg SD Zidovudine Capsule, 100 mg SD Zidovudine Syrup, 10 mg/ml SD Zidovudine Tablet, 300 mg SD Zidovudine + Lamivudine Tablet, 300 mg +150 mg SD 29.4 DRUGS FOR UROLOGY Tamsulosin Capsule, 400 microgram D Terazosin Tablet, 2 mg D Terazosin Tablet, 5 mg D Finasteride Tablet, 5 mg D Page 26 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO. P.O. Box MB-582, Accra, Ghana, West Africa Tel: +233 (0) 21 661 670/+233 (0) 21661671 Fax: +233 ©21 664309 E-mail: gndp@ighmail.com Website: www.moh-ghana.org ISBN 9988-8283-2-2 Page 27 of 27img.html 2007-05-17file://J:\DivData\ALLDOCS\MoniqueRenevier\EMLs from countries\Ghana_CD-RO.

View the publication

You are currently offline. Some pages or content may fail to load.